April 20, 2017: Mylan Laboratories Inc announced the U.S. launch of Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg, a generic version of the reference listed drug, Trilafon Tablets 2 mg, 4 mg, 8 mg and 16 mg, originally marketed by Schering. Mylan received final approval from the U.S. Food and (Read More….)
March 8, 2017: Teligent announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Clobetasol Propionate Gel, 0.05%. This is Teligent’s second approval for 2017, and its thirteenth approval from its internally-developed pipeline of topical generic pharmaceutical medicines.
Based on recent QuintilesIMS Health (Read More….)
February 28, 2017: Endo International reports Q4 EPS of $1.77 versus the $1.63 estimate. Revenue also beat coming in at $1.24 billion versus the $1.15 billion estimate.
CEO Paul Campanelli said, “Endo’s core assets include a Generics business, which is the fourth largest in the U.S. based on sales, that possesses a growing sterile (Read More….)
February 5, 2017: Sell Teva Pharmaceutical for a -1.54% loss. Sorry folks but better to get out for a small loss as not sure how big of penalties we’re looking at IF Teva is found guilty of actually doing what the State of California is saying they did but I’m thinking possibly hundreds of millions. (Read More….)
February 01, 2017: Lannett Company reports Q2 EPS of $0.92 versus the $0.83 estimate. Revenue also beat coming in at $170.9 million versus the $169 million estimate.
The CEO said, “Higher sales across a number of products and the addition of KU’s operations were key drivers to the 35% increase in our fiscal 2017 (Read More….)
January 17, 2017: Avondale Partners raised McKesson to Market Outperform from Market Perform.
January 17, 2017: McKesson agrees to $150 million settlement with DOJ over failure to report suspicious orders of drugs. The nationwide settlement requires McKesson to suspend sales of controlled substances from distribution centers in Colorado, Ohio, Michigan and Florida for multiple years. (Read More….)
January 12, 2017: CVS announced that a low-cost epinephrine auto-injector option, the authorized generic for Adrenaclick manufactured by Impax Laboratories (IPXL), is available at all CVS Pharmacy locations at a cash price of $109.99 for a two-pack. This compares to a cash price of $649.99 for EpiPenand $339.99 for the authorized generic for EpiPen.
The (Read More….)
January 9, 2017: Huron Consulting Group formed a doji today, in oversold territory, on news it acquired Pope Woodhead & Associates. Huron Consulting Group says that it has expanded its life sciences strategy expertise with the acquisition of Pope Woodhead & Associates. The UK-based consulting firm provides market access capabilities to assist clients in developing (Read More….)
January 6, 2017: Depomed Inc said to have received one bid according to reports in the mainstream financial media. Recent mainstream media commentary on potential sale of Depomed:
– On Dec 31st KKR remains interested in acquiring Depomed – NY Post
– One analyst cited expects a deal would value DEPO at $25/shr or $1.5 (Read More….)
January 4, 2017: Seeing heavy call activity in Alexion Pharmaceuticals: 2,000 Aug $140 calls traded at $12.80. I wonder if the heavy call activity has anything to do with the takeover rumors that were circulating on December 20, 2016, about Alexion Pharmaceuticals?
December 22, 2016: Leerink defending Alexion Pharmaceuticals; Reiterates outperform rating and price target (Read More….)
December 29, 2016: Sell Recro Pharmaceuticals for a 19.74% win in 11 trading days. Congratulations if you were able to make money on the trade.
December 19, 2016: Piper Jaffray/Simmons initiates coverage of Recro Pharmaceuticals with an Overweight rating, and sets a price target of $12.
December 14, 2016: Broadfin Capital discloses amended 16.43% stake (Read More….)
December 29, 2016: Sell Conatus Pharmaceuticals for a monster 23.02% gain in just 3 trading days. Congratulations if you were able to make money on the trade.
December 26, 2016: Biotechnology firm Conatus Pharmaceuticals gets a price target upgrade after news of deal with Novartis. JMP Securities raised the price target for Conatus Pharmaceuticals to (Read More….)
December 28, 2016: Tonix Pharmaceuticals is forming a wide J Hook pattern after having the FDA granted their PTSD drug TNX-102 a Breakthrough Therapy designation.
December 19, 2016: Tonix Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) had granted Breakthrough Therapy designation to TNX-102 SL for the treatment of posttraumatic stress disorder (Read More….)
Hillary Clinton and Democrats promised to wage war on pharmaceutical companies and do things like price controls on drugs and products of the biotechnology industry.
In California, there was a ballot measure to impose price controls on the sale of pharmaceutical drugs in the state.
Both Hillary Clinton’s probability of winning, and California’s (Read More….)